infectious disease, structural biology, immunology

The receptors, found in so-called elite controllers who don’t need medications to keep the virus in check, suggest a new path toward immunotherapy.

Engineered immunogens based on conserved patches of the virus’s envelope protein point to new strategies for vaccine design.